Detecting At-Risk Alzheimer’s Disease Cases

While APOE ɛ4 is the major genetic risk factor for Alzheimer’s disease (AD), amyloid dysmetabolism is an initial or early event predicting clinical disease and is an important focus for secondary intervention trials. To improve identification of cases with increased AD risk, we evaluated recruitment...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Alzheimers Dis
Главные авторы: Fladby, Tormod, Pålhaugen, Lene, Selnes, Per, Waterloo, Knut, Bråthen, Geir, Hessen, Erik, Almdahl, Ina Selseth, Arntzen, Kjell-Arne, Auning, Eirik, Eliassen, Carl Fredrik, Espenes, Ragna, Grambaite, Ramune, Grøntvedt, Gøril Rolfseng, Johansen, Krisztina Kunszt, Johnsen, Stein Harald, Kalheim, Lisa Flem, Kirsebom, Bjørn-Eivind, Müller, Kai Ivar, Nakling, Arne Exner, Rongve, Arvid, Sando, Sigrid Botne, Siafarikas, Nikias, Stav, Ane Løvli, Tecelao, Sandra, Timon, Santiago, Bekkelund, Svein Ivar, Aarsland, Dag
Формат: Artigo
Язык:Inglês
Опубликовано: IOS Press 2017
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5611830/
https://ncbi.nlm.nih.gov/pubmed/28826181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-170231
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы